Evidence map›Paper›PMID 25547674›Full record

ArticleThe Journal of experimental medicine2015

Whole-transcriptome analysis of endothelial to hematopoietic stem cell transition reveals a requirement for Gpr56 in HSC generation.

Parham Solaimani Kartalaei, Tomoko Yamada-Inagawa, Chris S Vink, Emma de Pater, Reinier van der Linden, Jonathon Marks-Bluth, Anthon van der Sloot, Mirjam van den Hout, Tomomasa Yokomizo, M Lucila van Schaick-Solernó and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Adhesion G protein-coupled receptors.Pharmacological reviews · 2026
    Review
  5. Gpr171 regulates embryonic hematopoietic stem cell emergence via ERK1/2 and Notch signaling.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. PDGFRβCell reports · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Parham Solaimani KartalaeiErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
Tomoko Yamada-InagawaErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
Chris S VinkErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
Emma de PaterErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
Reinier van der LindenErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
Jonathon Marks-BluthLowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia.
Anthon van der SlootErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
Mirjam van den HoutErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
Tomomasa YokomizoCancer Science Institute of Singapore, National University of Singapore, Singapore 117599.
M Lucila van Schaick-SolernóErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
Ruud DelwelErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
John E PimandaLowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia.
Wilfred F J van IJckenErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands.
Elaine DzierzakErasmus MC Stem Cell Institute, Department of Cell Biology, Center for Biomics, and Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, Netherlands e.dzierzak@erasmusmc.nl Elaine.Dzierzak@ed.ac.uk.
Stem Cell Institute · PAErasmus MC · NLUNSW Sydney · AUNational University of Singapore · SG

Funding

Characterization of the first HSCs during mouse ontogenyR37DK054077 · NIDDK · UNIVERSITY OF EDINBURGH · PI DZIERZAK, ELAINE A · 2006 to 2015
$2.7M
NIDDK NIH HHS R37 DK054077NIDDK NIH HHS R37DK054077
6 · The paper itself

Abstract

Hematopoietic stem cells (HSCs) are generated via a natural transdifferentiation process known as endothelial to hematopoietic cell transition (EHT). Because of small numbers of embryonal arterial cells undergoing EHT and the paucity of markers to enrich for hemogenic endothelial cells (ECs [HECs]), the genetic program driving HSC emergence is largely unknown. Here, we use a highly sensitive RNAseq method to examine the whole transcriptome of small numbers of enriched aortic HSCs, HECs, and ECs. Gpr56, a G-coupled protein receptor, is one of the most highly up-regulated of the 530 differentially expressed genes. Also, highly up-regulated are hematopoietic transcription factors, including the "heptad" complex of factors. We show that Gpr56 (mouse and human) is a target of the heptad complex and is required for hematopoietic cluster formation during EHT. Our results identify the processes and regulators involved in EHT and reveal the surprising requirement for Gpr56 in generating the first HSCs.

Indexed as

AnimalsCell LineCells, CulturedCell TransdifferentiationChlorocebus aethiopsCHO CellsCOS CellsCricetinaeCricetulusEmbryo, MammalianEndothelial CellsFemaleGene Expression ProfilingGene OntologyHematopoietic Stem CellsHumansADGRG1 protein, humanAdgrg1 protein, mouseReceptors, G-Protein-Coupled

Identifiers

PMID25547674
PMCPMC4291529
OpenAlexW2104849631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.